Literature DB >> 22225645

Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model.

Onkar V Khullar1, Aaron P Griset, Summer L Gibbs-Strauss, Lucian R Chirieac, Kimberly A V Zubris, John V Frangioni, Mark W Grinstaff, Yolonda L Colson.   

Abstract

BACKGROUND: The aim of this study was to demonstrate feasibility of migration and in situ chemotherapy delivery to regional lymph nodes (LN) in a large animal model using an expansile polymer nanoparticle (eNP) delivery system. STUDY
DESIGN: Dual-labeled 50-nm and 100-nm eNP were prepared by encapsulating an IR-813 near-infrared (NIR) fluorescent dye within coumarin-conjugated expansile polymer nanoparticles (NIR-C-eNP). NIR imaging and fluorescent microscopy were used to identify intralymphatic migration of NIR-nanoparticles to draining inguinal or mesenteric LN after injection in swine hind legs or intestine. Nanoparticle-mediated intranodal delivery of chemotherapy was subsequently assessed with Oregon Green paclitaxel-loaded NIR-eNP (NIR-OGpax-eNP).
RESULTS: NIR imaging demonstrated direct lymphatic migration of 50-nm, but not 100-nm, NIR-C-eNP and NIR-OGpax-eNP to the draining regional LNs after intradermal injection in the hind leg or subserosal injection in intestine. Fluorescent microscopy demonstrated that IR-813 used for NIR real-time trafficking colocalized with both the coumarin-labeled polymer and paclitaxel chemotherapy and was identified within the subcapsular spaces of the draining LNs. These studies verify nodal migration of both nanoparticle and encapsulated payload, and confirm the feasibility of focusing chemotherapy delivery directly to regional nodes.
CONCLUSIONS: Regionally-targeted intranodal chemotherapy can be delivered to draining LNs for both skin and solid organs using 50-nm paclitaxel-loaded eNP. Copyright Â
© 2012 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22225645      PMCID: PMC3288886          DOI: 10.1016/j.jamcollsurg.2011.11.006

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  38 in total

Review 1.  Liposomes to target the lymphatics by subcutaneous administration.

Authors:  C Oussoren; G Storm
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

Review 2.  In vivo near-infrared fluorescence imaging.

Authors:  John V Frangioni
Journal:  Curr Opin Chem Biol       Date:  2003-10       Impact factor: 8.822

Review 3.  Lymphatic dissemination of tumour cells and the formation of micrometastases.

Authors:  Philippe O Van Trappen; Michael S Pepper
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

4.  In vivo near-infrared fluorescence imaging of osteoblastic activity.

Authors:  A Zaheer; R E Lenkinski; A Mahmood; A G Jones; L C Cantley; J V Frangioni
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

5.  Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter.

Authors:  J Wu; Y Ohta; H Minato; Y Tsunezuka; M Oda; Y Watanabe; G Watanabe
Journal:  Ann Thorac Surg       Date:  2001-06       Impact factor: 4.330

6.  The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.

Authors:  D J Dewar; B Newell; M A Green; A P Topping; B W E M Powell; M G Cook
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

Review 7.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

Review 8.  Lymphatic metastasis.

Authors:  I Carr
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

9.  Histopathological patterns of melanoma metastases in sentinel lymph nodes.

Authors:  C A Murray; W L Leong; D R McCready; D M Ghazarian
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

10.  Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.

Authors:  Jianghao Chen; Ling Wang; Qing Yao; Rui Ling; Kaizong Li; Hui Wang
Journal:  Breast Cancer Res       Date:  2004-06-17       Impact factor: 6.466

View more
  13 in total

1.  A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep.

Authors:  Gemma M Ryan; Robert J Bischof; Perenlei Enkhbaatar; Victoria M McLeod; Linda J Chan; Seth A Jones; David J Owen; Christopher J H Porter; Lisa M Kaminskas
Journal:  Pharm Res       Date:  2015-10-20       Impact factor: 4.200

Review 2.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

3.  Intelligent Nanoparticles for Advanced Drug Delivery in Cancer Treatment.

Authors:  David S Spencer; Amey S Puranik; Nicholas A Peppas
Journal:  Curr Opin Chem Eng       Date:  2015-02       Impact factor: 5.163

4.  Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation.

Authors:  John C Kraft; Lisa A McConnachie; Josefin Koehn; Loren Kinman; Jianguo Sun; Ann C Collier; Carol Collins; Danny D Shen; Rodney J Y Ho
Journal:  J Control Release       Date:  2018-02-10       Impact factor: 9.776

5.  Impact of Locally Administered Carboxydextran-Coated Super-Paramagnetic Iron Nanoparticles on Cellular Immune Function.

Authors:  Luisa Pedro; Quentin Harmer; Eric Mayes; Jacqueline D Shields
Journal:  Small       Date:  2019-04-15       Impact factor: 13.281

Review 6.  Innovations in lymph node targeting nanocarriers.

Authors:  Jihoon Kim; Paul A Archer; Susan N Thomas
Journal:  Semin Immunol       Date:  2021-11-24       Impact factor: 11.130

7.  Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles.

Authors:  Rong Liu; Denis M Gilmore; Kimberly Ann V Zubris; Xiaoyin Xu; Paul J Catalano; Robert F Padera; Mark W Grinstaff; Yolonda L Colson
Journal:  Biomaterials       Date:  2012-12-08       Impact factor: 12.479

8.  Microscopy and tunable resistive pulse sensing characterization of the swelling of pH-responsive, polymeric expansile nanoparticles.

Authors:  Aaron H Colby; Yolonda L Colson; Mark W Grinstaff
Journal:  Nanoscale       Date:  2013-03-13       Impact factor: 7.790

Review 9.  From Diagnosis to Treatment: Clinical Applications of Nanotechnology in Thoracic Surgery.

Authors:  Christopher S Digesu; Sophie C Hofferberth; Mark W Grinstaff; Yolonda L Colson
Journal:  Thorac Surg Clin       Date:  2016-05       Impact factor: 1.750

Review 10.  Control of polymeric nanoparticle size to improve therapeutic delivery.

Authors:  John W Hickey; Jose Luis Santos; John-Michael Williford; Hai-Quan Mao
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.